30,493 Shares in CVS Health Corporation $CVS Bought by Meiji Yasuda Asset Management Co Ltd.

Meiji Yasuda Asset Management Co Ltd. bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 30,493 shares of the pharmacy operator’s stock, valued at approximately $3,155,000.

Several other hedge funds have also modified their holdings of CVS. Clarion Wealth Managment Partners LLC purchased a new stake in CVS Health during the second quarter valued at about $227,000. Te Ahumairangi Investment Management Ltd purchased a new position in shares of CVS Health in the second quarter worth approximately $4,058,000. Kiltearn Partners LLP acquired a new stake in shares of CVS Health during the second quarter valued at approximately $35,739,000. Haverford Trust Co acquired a new stake in shares of CVS Health during the second quarter valued at approximately $2,074,000. Finally, First Nebraska Trust Co purchased a new stake in shares of CVS Health in the 2nd quarter valued at approximately $692,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 1.1%

Shares of CVS stock opened at $94.06 on Tuesday. The stock’s 50 day simple moving average is $101.88 and its 200 day simple moving average is $89.08. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a market capitalization of $120.31 billion, a price-to-earnings ratio of 24.88, a PEG ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the company posted $1.81 earnings per share. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is 70.37%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CVS. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. TD Cowen raised their target price on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Truist Financial lifted their price target on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Finally, Sanford C. Bernstein raised their price objective on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.